Paper41596641
Metabolomics for Preclinical Detection of Diabetic Kidney Disease: A Comprehensive Review.
Garoufis M and 4 others. Int J Mol Sci, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Metabolomics for Preclinical Detection of Diabetic Kidney Disease: A Comprehensive Review. Papers, record 41596641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41596641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Metabolomics for Preclinical Detection of Diabetic Kidney Disease: A Comprehensive Review.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Metabolomics | Major topic |
| Diabetic Nephropathies | Major topic |
| Humans | |
| Animals | |
| Biomarkers | |
| Energy Metabolism |
Source PubMed
References74
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27692817 | An overview of renal metabolomics. | Kidney Int | 2017 | https://conductscience.org/library/papers/27692817 | PubMed |
| 2 | 40212952 | Metabolomics for the Identification of Biomarkers in Kidney Diseases. | Nanotheranostics | 2025 | https://conductscience.org/library/papers/40212952 | PubMed |
| 3 | 15788407 | Single cell analysis and temporal profiling of agonist-mediated inositol 1,4,5-trisphosphate, Ca2+, diacylglycerol, and protein kinase C signaling using fluorescent biosensors. | J Biol Chem | 2005 | https://conductscience.org/library/papers/15788407 | PubMed |
| 4 | 39651975 | 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2025. | Diabetes Care | 2025 | https://conductscience.org/library/papers/39651975 | PubMed |
| 5 | 35008760 | OMICS in Chronic Kidney Disease: Focus on Prognosis and Prediction. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/35008760 | PubMed |
| 6 | 34560098 | Kidney disease in diabetes: From mechanisms to clinical presentation and treatment strategies. | Metabolism | 2021 | https://conductscience.org/library/papers/34560098 | PubMed |
| 7 | 35601149 | Artemether Alleviates Diabetic Kidney Disease by Modulating Amino Acid Metabolism. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/35601149 | PubMed |
| 8 | 16952978 | Mechanisms of diabetic nephropathy: role of hypertension. | Hypertension | 2006 | https://conductscience.org/library/papers/16952978 | PubMed |
| 9 | 35283173 | Americentrism in estimation of glomerular filtration rate equations. | Kidney Int | 2022 | https://conductscience.org/library/papers/35283173 | PubMed |
| 10 | 30217994 | Metabolomic Profile Predicts Development of Microalbuminuria in Individuals with Type 1 Diabetes. | Sci Rep | 2018 | https://conductscience.org/library/papers/30217994 | PubMed |
| 11 | 19198800 | Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. | Diabetologia | 2009 | https://conductscience.org/library/papers/19198800 | PubMed |
| 12 | 29520581 | Biomarkers of diabetic kidney disease. | Diabetologia | 2018 | https://conductscience.org/library/papers/29520581 | PubMed |
| 13 | 28262773 | Metabolomics for clinical use and research in chronic kidney disease. | Nat Rev Nephrol | 2017 | https://conductscience.org/library/papers/28262773 | PubMed |
| 14 | 25382277 | PLS/OPLS models in metabolomics: the impact of permutation of dataset rows on the K-fold cross-validation quality parameters. | Mol Biosyst | 2015 | https://conductscience.org/library/papers/25382277 | PubMed |
| 15 | 12879251 | Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. | Diabetologia | 2003 | https://conductscience.org/library/papers/12879251 | PubMed |
| 16 | 31390268 | Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy. | Am J Physiol Renal Physiol | 2019 | https://conductscience.org/library/papers/31390268 | PubMed |
| 17 | 34363037 | Trajectories of kidney function in diabetes: a clinicopathological update. | Nat Rev Nephrol | 2021 | https://conductscience.org/library/papers/34363037 | PubMed |
| 18 | 37509122 | Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients. | Biomolecules | 2023 | https://conductscience.org/library/papers/37509122 | PubMed |
| 19 | 33528734 | Novel biomarkers of diabetic kidney disease: current status and potential clinical application. | Acta Diabetol | 2021 | https://conductscience.org/library/papers/33528734 | PubMed |
| 20 | 30518813 | Estimated GFR: time for a critical appraisal. | Nat Rev Nephrol | 2019 | https://conductscience.org/library/papers/30518813 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42517613 | Di(2-Ethylhexyl) Phthalate Exposure and Risk of Diabetic Kidney Disease: Epidemiological Association and Mechanistic Insights. | Diabetes Metab Res Rev | 2026 | https://conductscience.org/library/papers/42517613 | PubMed |
| 42514233 | Biomarkers in Diabetic Kidney Disease: Early Detection, Prognostic Assessment, and Integration with Multi-Omics Signatures. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42514233 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41596641
GET https://conductscience.org/api/papers/v1/41596641/references?page=2